What amount sold does Altesa BioSciences, Inc. report in Form D filings?

The latest linked filings report $110M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Altesa BioSciences, Inc.'s most recent SEC filing?

Altesa BioSciences, Inc.'s most recent Form D filing was on 2026-02-23.

How many investors does Altesa BioSciences, Inc. have?

The most recent Form D filing lists 17 investor(s).

What type of securities does Altesa BioSciences, Inc. offer?

Altesa BioSciences, Inc.'s SEC Form D filings indicate equity offerings.

Altesa BioSciences, Inc.

CIK: 0001960618·Pharmaceuticals·COLLEGE PARK, GA·Corporation

Reported Sold

$109,999,986

Total Filings

Identified Offerings

Last Filed

Feb 23, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Feb 23, 2026Form D — New notice

Reported sold: $74,999,986 · Target: $74,999,986

Rule 506(b)·17 investors

Jul 7, 2023Form D/A — Amendment

Reported sold: $35,000,000 · Target: $35,000,000

Rule 506(b)·18 investors

Changed: Reported amount sold, Offering target, Reported investors

Jan 5, 2023Form D — New notice

Reported sold: $14,864,973 · Target: $30,000,000

Rule 506(b)·16 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

33%

Latest reported sold across 2 identified offerings

$109,999,986

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

John Clerici

Related Person

Appears on 3 filings

Brett Giroir

Related Person

Appears on 3 filings

Seth Rudnick

Related Person

Appears on 3 filings

Ittai Harel

Related Person

Appears on 3 filings

Moncef Slaoui

Related Person

Appears on 3 filings

Nicholas Williams

Related Person

Appears on 2 filings

Andrew Drechsler

Related Person

Appears on 1 filing

Jon Edwards

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Feb 23, 2026	New	$74,999,986	$74,999,986	17
Jul 7, 2023	Amendment	$35,000,000	$35,000,000	18
Jan 5, 2023	New	$30,000,000	$14,864,973	16

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Land Therapeutics Inc.

Pharmaceuticals

Offering target: $92,111,706

Filed Oct 20, 2026